| Literature DB >> 21318186 |
Marisa M Geens1, Theo A Niewold.
Abstract
IPEC-J2, a promising in vitro model system, is not well characterized especially on the transcriptional level, in contrast to human counterparts. The aim of this study was to characterize the gene expression in IPEC-J2 cells when coincubated with enterotoxigenic Escherichia coli (ETEC), nonpathogenic E. coli, and E. coli endotoxin. Apical infection of polarized IPEC-J2 monolayers caused a time-dependent decrease in transepithelial electrical resistance (TEER). Microarray analysis showed up-regulation of interleukins when IPEC-J2 were cocultured with E. coli strains this has so far never been measured in this cell line. Highest IL8 expression was found with the ETEC strain possessing the F4 fimbrium, suggesting IPEC-J2 cells to be F4 receptor positive, confirmed in a brush border membrane adhesion assay. It is concluded that the innate immune responses to pathogens and LPS makes the IPEC-J2 cell line a suitable model for research on intestinal host pathogen interaction.Entities:
Year: 2010 PMID: 21318186 PMCID: PMC3034941 DOI: 10.1155/2010/469583
Source DB: PubMed Journal: Comp Funct Genomics ISSN: 1531-6912
Different inflammatory stimuli with their specifications and concentrations used.
| LPS | Enterotoxins LT and STb | Fimbrium | Concentration | |
|---|---|---|---|---|
| Lipopolysaccharide | + | 1 | ||
| CVI-444 | + | F1 | MOI = 1 : 10 | |
| CVI-1000 | + | + | F4 | MOI = 1 : 10 |
| CVI-1048 | + | + | MOI = 1 : 10 |
Primer sequences used in this study.
| Symbol | Name | Probe set ID | Forward primer | Reverse primer |
|---|---|---|---|---|
| RPL4 | Ribosomal protein L4 | Ssc.12277.1.S1_at | GAGAAACCGTCGCCGAAT | GCCCACCAGGAGCAAGTT |
| YWHAZ | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | Ssc.9681.1.A1_at | AGCAGATGGCTCGAGAAT | GCAACCTCAGCCAAGTAAC |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | Ssc.14942.1.S1_at | GGTCGGAGTGAACGGATTTG | ACTGTGCCGTGGAATTTGC |
| ACTB | Beta actin | Ssc.13874.1.S1_at | CTACGTCGCCCTGGACTTC | GATGCCGCAGGATTCCAT |
| B2M | Beta-2-microglobulin | Ssc.12348.1.S1_at | TCGGGCTGCTCTCACTGT | GACTGCTCCGCGTTCATC |
| IL8 | Interleukin-8 | Ssc.658.1.S1_at | TCACAAGCTCCTAGGACCAGA | CAGAACTGCAGCCTCACAGA |
| PAP | Pancreatitis-associated protein | Ssc.16470.1.S1_at | GAAGATTCCCCAGCAGACAC | AGGACACGAAGGATGCCTC |
| FABP1 | Liver fatty acid binding protein | Ssc.604.1.S1_at | CCAAGTACAGAGCCAGGAAAA | CCCGGTAGTGATGGTCAACT |
| FABP2 | Intestinal fatty acid binding protein | Ssc.16525.1.S1_at | TGAATCAGCTGGAGACTATGG | TTTACCACGTTAATACCCATTTTT |
| FABP5 | Epidermal fatty acid binding protein | Ssc.5549.1.S1_at | CCAGGCTCTAGGCACCAGT | GGCCATTCCCACTCCTACTT |
| IRG6 | Inflammatory response protein 6 | Ssc.286.1.S1_s_at | CATCAATCGCTTCAATGTGG | ACCAAGCAGGACACGTCTTT |
| CYP1A1 | Cytochrome P450 1A1 | Ssc.208.1.S1_at | CAACACGTCCCTGGATCTCT | ATCCGACAGCTGGATATTGG |
Microarray data expressed as a log2 fold change of the transcriptional response of IPEC-J2 cocultured with inflammatory stimuli as compared to the control. Genes common to at least two out of four treatments are given (for full list see Supplementary Material).
| log2 fold change | ||||||||
|---|---|---|---|---|---|---|---|---|
| Probeset ID | LPS versus control | CVI-444 versus control | CVI-1000 versus control | CVI-1048 versus control | Public ID | Gene title | Gene symbol | Tentative function (UniProtKB) |
| Ssc.19163.1.S1_at | −1,51 | −1,42 | −1,10 | −1,71 | BF078930 | Transcribed locus | — | |
| Ssc.19268.2.A1_at | −1,09 | −1,09 | −1,11 | −1,16 | CF359637 | Transcribed locus, moderately similar to NP_660274.1 chromosome 14 open reading frame 143 ( | — | Calcium ion binding |
| AFFX-SSC-28SrRNA_at | −1,16 | −1,46 | −1,26 | −1,20 | AFFX-SSC-28SrRNA |
| — | |
| Ssc.24007.1.S1_at | 2,16 | 1,04 | 1,38 | 1,68 | CK450048 | Paternally expressed 10 | PEG10 | Nucleic acid binding |
| Ssc.15937.1.A1_at | 1,50 | 1,54 | 1,41 | 1,62 | AF248308.1 | Transcribed locus, moderately similar to XP_375341.1 similar to Ig heavy chain - human (fragment) ( | — | |
| Ssc.19692.1.S1_at | 1,34 | 1,87 | 1,92 | BF078671 | Chemokine (C-X-C motif) ligand 2 | CXCL2 | Immune response | |
| Ssc.4871.1.S1_at | 1,85 | 2,21 | 2,57 | NM_001001861.1 | Chemokine (C-X-C motif) ligand 2 | CXCL2 | Immune response | |
| Ssc.658.1.S1_at | 1,93 | 2,29 | 2,18 | NM_213867.1 | Interleukin 8 | IL8 | Cytokine, inflammatory response, immune response | |
| Ssc.14467.2.S1_a_at | 1,99 | 1,24 | 1,14 | AY028311.1 | Amphiregulin | AREG | Cytokine, growth factor | |
| Ssc.286.1.S1_s_at | −1,72 | −1,84 | NM_213817.1 | Inflammatory response protein 6 | IRG6 | Antiviral defense, defense response to virus | ||
| Ssc.208.1.S1_at | 2,22 | 2,75 | 1,83 | NM_214412.1 | Cytochrome P450 1A1 | CYP1A1 | Oxidation reduction | |
| Ssc.113.1.S2_at | 1,12 | 2,16 | NM_214029.1 | Interleukin 1, alpha | IL1A | Cytokine, inflammatory response, immune response | ||
| Ssc.113.1.S1_at | 1,28 | 2,58 | M86730.1 | Interleukin 1, alpha | IL1A | Cytokine, inflammatory response, immune response | ||
| Ssc.10453.1.S1_at | −1,07 | −1,42 | BF713714 | Transcribed locus, highly similar to NP_000087.1 ceruloplasmin (ferroxidase) ( | — | Oxidoreductase, transport | ||
| Ssc.26317.1.S1_at | 1,23 | −1,55 | AY509877.1 | Alpha-2-macroglobulin | A2M | Endopeptidase inhibitor activity | ||
| Ssc.7090.1.A1_at | 1,46 | −1,48 | NM_214395.1 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | SERPINA1 | Protease inhibitor, serine protease inhibitor | ||
| Ssc.16053.1.S1_at | −1,08 | AF069643.1 | Matrix metalloproteinase 13 precursor | MMP-13 | Hydrolase, protease, metalloprotease | |||
| Ssc.4368.3.S1_at | −1,73 | −1,19 | BP463181 | F-box protein 32 | FBXO32 | Ubl conjugation pathway | ||
| Ssc.4368.1.S1_at | −1,59 | −1,32 | BI817204 | F-box protein 32 | FBXO32 | Ubl conjugation pathway | ||
| Ssc.221.1.S1_at | −1,09 | −1,55 | NM_214061.1 | Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 | MX1 | Antiviral defense, reponse to virus | ||
| Ssc.21.1.S1_s_at | −1,05 | −1,66 | AF319661.1 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | DDX58 | Antiviral defense, immune response, innate immunity | ||
| Ssc.15888.1.S1_at | −1,22 | −1,07 | NM_213805.1 | Oxidized low density lipoprotein (lectin-like) receptor 1 | OLR1 | Cell adhesion, immune response, inflammatory response | ||
| Ssc.16648.1.S1_at | −1,28 | −1,35 | −2,30 | −3,34 | CK458095 | Thioredoxin interacting protein | TXNIP | Cell cycle, transcription, transcription regulation |
Figure 1Linear regression of qRT-PCR data versus microarray data of IL8, IRG6, CYP1A1 and FABP5. The goodness of fit (r 2) and P-value are given.
Figure 2qRT-PCR analysis of IL8, IRG6, CYP1A1 and FABP5, in response to the four treatments at 4 h. LPS (1), CVI-444 (2), CVI-1000 (3) and CVI-1048 (4) (mean with S.D. of n = 5-6). Asterisks indicate significant differences between treatments. *.05 < P < .01, **.01 < P < .005, ***P < .005.
Figure 3Intracellular concentration of I-FABP (mean ± S.D. of n = 6–8) in the three different cell lines during 14 days of culture (open circle: IPEC-J2 cells, closed triangle: COS-7 cells and closed rectangle: T84 cells).
Bacterial adhesion assay in the presence of 1% D-mannose. Numbers are the average (±S.D.) of adherent bacteria per cell or brush border (N.A. = not applicable).
|
| F4R+ brush border membranes | IPEC-J2 14d culture flask | IPEC-J2 10d membrane support | IPEC-J2 15d membrane support | IPEC-J2 21d membrane support |
|---|---|---|---|---|---|
| CVI-444 (F1+) | N.A. | 0.31 ± 0.74 | 0.58 ± 1.16 | 0.29 ± 0.49 | 0.30 ± 0.47 |
| CVI-1000 (F4+) | 2.17 ± 1.88 | 9.17 ± 7.20 | 2.82 ± 4.26 | 7.43 ± 5.72 | 7.59 ± 5.47 |
| CVI-1048 (F4-) | 0.00 ± 0.00 | 0.63 ± 1.01 | 0.62 ± 0.77 | 0.67 ± 0.98 | 0.86 ± 0.90 |
Development of the transepithelial electrical resistance (TEER, in kΩ cm2 as average (±S.D.)) in time. Letters indicate significant differences in the same row. Last column shows final TEER values as a percentage of 0 h.
| 0 h | 2 h | 4 h | 4 h versus 0 h (%) | |
|---|---|---|---|---|
| control | 6.11 ± 1.17(a) | 5.64 ± 1.13(b) | 5.73 ± 1.03(b) | 94 |
| LPS | 3.50 ± 0.84(a) | 2.62 ± 0.80(b) | 2.74 ± 0.99(b) | 78 |
| CVI-444 | 4.62 ± 1.30(a) | 3.38 ± 1.07(b) | 2.90 ± 0.92(b) | 63 |
| CVI-1000 | 4.85 ± 1.24(a) | 4.01 ± 0.98(b) | 0.10 ± 0.15(c) | 2 |
| CVI-1048 | 4.84 ± 1.04(a) | 3.76 ± 0.79(b) | 1.29 ± 0.65(c) | 27 |